Literature DB >> 7943250

Concurrent generation of nitric oxide and superoxide damages surfactant protein A.

I Y Haddad1, J P Crow, P Hu, Y Ye, J Beckman, S Matalon.   

Abstract

The conditions under which nitric oxide (.NO) may modulate or promote lung injury have not been identified. We hypothesized that .NO-induced injury results from peroxynitrite, formed by the reaction of .NO with superoxide. The simultaneous generation of .NO and superoxide by 3-morpholinosydnonimine (SIN-1, 0.1-2 mM) resulted in oxidation of dihydrorhodamine, a marker of peroxynitrite production, and a dose-dependent decrease in the ability of SP-A to enhance lipid aggregation. Western blot analysis of SIN-1 exposed SP-A samples, overlaid with a polyclonal antibody against nitrotyrosine, were consistent with nitration of SP-A tyrosine residues. Superoxide dismutase (100 U/ml), L-cysteine (5 mM), xanthine oxidase (10 mU/ml) and xanthine (500 microM), or urate (100 microM) prevented the SIN-1-induced dihydrorhodamine oxidation and injury to SP-A. .NO alone, generated by S-nitroso-N-acetylpenicillamine plus 100 microM L-cysteine, or superoxide and hydrogen peroxide, generated by pterin and xanthine oxidase in the absence of iron, did not damage SP-A or oxidize dihydrorhodamine. We concluded that peroxynitrite, but not .NO or superoxide and hydrogen peroxide, in concentrations likely to be encountered in vivo, caused nitrotyrosine formation and decreased the ability of SP-A to aggregate lipids.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943250     DOI: 10.1152/ajplung.1994.267.3.L242

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

1.  NOS-2 Inhibition in Phosgene-Induced Acute Lung Injury.

Authors:  Piotr T Filipczak; Albert P Senft; JeanClare Seagrave; Waylon Weber; Philip J Kuehl; Laura E Fredenburgh; Jacob D McDonald; Rebecca M Baron
Journal:  Toxicol Sci       Date:  2015-04-13       Impact factor: 4.849

2.  Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria.

Authors:  T J Evans; L D Buttery; A Carpenter; D R Springall; J M Polak; J Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

3.  New targets for surfactant replacement therapy: experimental and clinical aspects.

Authors:  B Robertson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

Review 4.  Pathophysiological roles of peroxynitrite in circulatory shock.

Authors:  Csaba Szabó; Katalin Módis
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

5.  3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method.

Authors:  J Khan; D M Brennand; N Bradley; B Gao; R Bruckdorfer; M Jacobs; D M Brennan
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 6.  Inhaled vasodilator therapy in acute lung injury: first, do NO harm?

Authors:  S J Brett; T W Evans
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

7.  Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro.

Authors:  E Sato; K L Simpson; M B Grisham; S Koyama; R A Robbins
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

8.  Bilirubin oxidation products (BOXes): synthesis, stability and chemical characteristics.

Authors:  W L Wurster; G J Pyne-Geithman; I R Peat; J F Clark
Journal:  Acta Neurochir Suppl       Date:  2008

9.  Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Jason R Mock; Yoshiki Eto; Brian T Garibaldi; Daniel C Files; Claudia R Avalos; Jackie V Rodriguez; Adam T Waickman; Sekhar P Reddy; David B Pearse; Venkataramana K Sidhaye; Paul M Hassoun; Michael T Crow; Landon S King
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

10.  Mitigation of chlorine-induced lung injury by low-molecular-weight antioxidants.

Authors:  Martin Leustik; Stephen Doran; Andreas Bracher; Shawn Williams; Giuseppe L Squadrito; Trenton R Schoeb; Edward Postlethwait; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-15       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.